SCHEMBL21761246

SCHEMBL21761246

COc1cc2ncnc(Nc3ccc(F)c(C)c3)c2cc1NC=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.58
▸ KDR P35968 10/20 0.58
▸ ERBB2 P04626 2/20 0.58
▸ FBP1 P09467 2/20 0.58
▸ CLK1 P49759 2/20 0.58
▸ RET P07949 2/20 0.58
▸ KIF5B P33176 2/20 0.58
▸ AURKA O14965 1/20 0.58
▸ INSR P06213 1/20 0.58
▸ PDGFRB P09619 1/20 0.58
▸ FLT4 P35916 1/20 0.58
▸ EPHB4 P54760 1/20 0.58
▸ TEK Q02763 1/20 0.58
▸ AURKB Q96GD4 1/20 0.58
▸ RIPK2 O43353 1/20 0.58
▸ NOD1 Q9Y239 1/20 0.58
▸ ERBB3 P21860 1/20 0.58
▸ DUS2 Q9NX74 1/20 0.58
▸ ERBB4 Q15303 1/20 0.56
▸ ABCG2 Q9UNQ0 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18862875 0.89 EGFR (0.75) EGFRKDRERBB2FBP1CLK1
SCHEMBL12846249 0.82 EGFR (0.64) EGFRKDRERBB2FBP1CLK1
SCHEMBL18862756 0.80 EGFR (0.58) EGFRKDRERBB2RETFLT4
SCHEMBL19220799 0.80 KDR (0.73) EGFRKDRERBB2FBP1CLK1
SCHEMBL18632967 0.79 FBP1 (0.76) EGFRKDRERBB2FBP1CLK1
SCHEMBL24948889 0.79 EGFR (0.66) EGFRKDRERBB2FBP1CLK1
SCHEMBL10108265 0.79 EGFR (0.72) EGFRERBB2RETPDGFRBRIPK2
SCHEMBL25707230 0.78 RET (0.68) EGFRKDRERBB2FBP1CLK1
SCHEMBL15781191 0.78 EGFR (0.67) EGFRERBB2RIPK2ERBB3DUS2
SCHEMBL21473661 0.78 KDR (0.70) EGFRKDRERBB2FBP1CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022186-B1 QUINAZOLINE DERIVATIVES, COMPOSITIONS THEREOF, AND USE AS PHARMACEUTICALS SHANGHAI FOCHON PHARMACEUTICAL CO LTD (CN) 2020-02-26 — — EP disclosed
Send feedback